APPLICATIONS PUBLISHED 29 JUNE 2005

Modified release dosage forms
McNeil-PPC 1545452*

Methods and reagents for treating infections of Clostridium difficile, and diseases associated therewith
Activbiotics 1545453*

Fast releasing, solid administration form for oral application of active ingredients which are hard to dissolve
Capsulation Nanoscience 1545454*

Controlled delivery system for bioactive substances
Universiteit Gent 1545455*

Pharmaceutical compsn containing keto-acids for endoperitoneal administration
Medestea Research & Production 1545456*

Cell transport compsns and uses thereof
Mannkind Corp 1545457*

Buccal, polar or non-polar spray or capsule containing drugs for treating an infectious disease or cancer
Novadel Pharma 1545458*

Insulin molecule having protracted time action
Eli Lilly 1545460*

Combined immediate release and extended release analgesic compsn
Endo Pharmaceuticals 1545461*

Dendrimers as molecular translocators
The Regents of the University of California 1545462*

Crystalline drug particles prepared using a controlled precipitation (recrystallisation) process
Dow Global Technologies 1545463*

Delayed release antiviral product, use and formulation thereof
Advancis Pharmaceutical 1545465*

Solid pharmaceutical formulations comprising telmisartan
Boehringer Ingelheim International 1545467*

Sustained-release opioid formulations and methods of use
Alpharma 1545468*

Methods to improve pharmaceutical tablets having a matrix of cellulose ether
Akzo Nobel 1545469*

Storage stable tablets of fosinopril sodium
Ranbaxy Laboratories 1545471*

Delayed release formulations for oral administration of a polypeptide therapeutic agent and methods of using same
Wyeth 1545474*

Chronotherapeutic diltiazem formulations and the administration thereof
Biovail Laboratories 1545476*

Compsns of ezetimibe and methods for the treatment of cholesterol-associated benign and malignant tumours
Karykion; The Children's Medical Center Crop 1545479*

Combination chemotherapy compsns and methods
Novogen Research 1545481*

Novel nitric oxide-releasing amidine diazeniumdiolates, compsns and uses thereof and method of making same
The Government of the United States of America, represented by the Department of Health and Human Services 1545482*

Non-nucleoside reverse transcriptase inhibitors
Ribapharm 1545483*

Pharmaceutical compsn comprising crystalline sibutramine methanesulphonate hemihydrate
Harni Pharm. Co 1545484*

Treatment of CNS disorders with trans-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine
Sepracor 1545485*

Use of bupropion for the manufacture of a medicament for treating restless legs syndrome
Pharmacia & Upjohn 1545486*

Use of a SRI and vitamin B6 for the treatment of neurological and mental disorders
Pantarhei Bioscience 1545487*

Choline ascorbate formulations
BASF 1545488*

Treatment of depression secondary to pain (DSP)
Cypress Bioscience 1545489*

Fosfomycin and N-acetylcysteine for the treatment of biofilms caused by Eschericia coli and other pathogens of the urinary tract
Zambon Group 1545490*

Therapeutic use of fused bicyclic or tricyclic amino acids
Pfizer 1545491*

Conjugated linoleic acid powder
Natural ASA 1545492*

Methods and compsns to treat conditions associated with neovascularisation
Mackvom 1545493*

Use of propionyl L-carnitine for the preparation of a medicament for the treatment of glaucoma
Sigma-Tau Industrie Farmaceutiche Riunite 1545494*

P-glycoprotein inhibitor comprising octilonium bromide as an effective ingredient
Korea Institute of Science and Technology 1545495*

Backbone-substituted bifunctional DOTA ligands, complexes and compsns thereof, and methods for using the same
The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services 1545498*

Compsns for solubilisation of paclitaxel and preparation method thereof
Korea Institute of Science and Technology 1545499*

Paclitaxel compsn for the intravesical treatment of bladder tumour and preparation method thereof
Korea Institute of Science and Technology 1545500*

Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma
Alcon 1545501*

Keto cannabinoids with therapeutic indications
The University of Connecticut 1545502*

Pharmaceutical formulations and methods for modified release of statin drugs
Bioavail Laboratories 1545503*

Non-psychotropic cannabinoids for prevention of cognitive impairment
Pharos Corp 1545504*

Drug-loaded biological material chemically treated with genipin
GP Medical 1545505*

Use of angelicin and of its structural analogues for the treatment of thalassemia
Università Degli Studi di Ferrara; Associated Veneta per la Lotta alla Talassemia 1545506*

Activated checkpoint therapy and methods of use thereof
Arqule; Beth Israel Deaconess Medical Centre 1545507*

3,6-disubstituted asabicyclo [3.1.0] hexane derivatives useful as muscarinic receptor antagonist
Ranbaxy Laboratories 1545508*

Caspase inhibitors as anticancer agents
University of Rochester 1545509*

Substituted phenylindoles for the treatment of HIV
Idenix (Cayman); Universitå`Degli Studi di Cagliari 1545510*

Combined use of methylphenidate and melatonin for treating attention-deficit hyperactive disorder
Pooger Properties 1545511*

Methods of using gold (III) complexes as anti-tumour and anti-HIV agents
The University of Hong Kong 1545512*

Compounds, compsns and methods for treating or preventing pneumovirus infection and associated diseases
Viropharma Incorporated 1545513*

Anticoagulant and fibrinolytic therapy using P38 MAP kinase inhibitors
Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharma KG 1545514*

3-pyrrolyl-pyridolpyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors
Sugen 1545515*